700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Case Report Open Access
Nasal passages form one of the chief sources of contact of the human with his environ-ment. Hence, it is natural that the mucosa of the area is the victim of assault with multi-tudes of potential allergens. Allergic rhinitis is an inflammatory disease with worldwide prevalence of 10-40%. Clinically allergic rhini-tis manifests as itching, sneezing, rhinorrhea, congestion and itchy eyes. Allergic rhinitis is a disease with low mortality but significantly lowers the quality of life and functioning. Both oral and intranasal antihistamines are approved for the first-line treatment of aller-gic rhinitis and both formulations result in a reduction in symptoms and an improvement in quality of life. The following study was de-signed to assess the efficacy and safety of the azelastine nasal spray in comparison to levocetrizine in patients with allergic rhinitis. Out of the 68 patients, 34 cases were treated with topical azelastine (group A), while remain-ing 34 with systemic levocetrizine (group B). The effects of anti-allergic drugs have been studied on the basis of relief of symptoms and change in histopathology. Comparing the post therapy clinical and histopathological results in this study, azelastine nasal spray was found to be more effective and safe in the treatment of al-lergic rhinitis than levocetrizine.
To read the full article Peer-reviewed Article PDF
Author(s): Mohit Srivastava Sunil Kumar Singh Bhadouriya Rohit Saxena Vandana singh Abhinav Srivastava Mamta Bisht